Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes
NCT: NCT07372872 · RECRUITING
Brief Summary
The goal of this pilot study is to test the feasibility and preliminary impact of "MyGlucoCare," a smartphone-based program designed to support women with gestational diabetes (GDM). The main questions it aims to answer are: Is the "MyGlucoCare" program practical and acceptable for participants? Does it show preliminary signs of improving self-management, blood sugar control, and well-being in women with gestational diabetes (GDM)? Researchers will conduct a single-arm study to gather initial data on the program's use and effects, which will be used to plan a larger future clinical trial. Participants will: Use the "MyGlucoCare" app for 8-12 weeks during their pregnancy. Receive personalized education, support from a clinician, and access to a moderated peer group through the app. Complete questionnaires and log health data via the app at the start, near the end of pregnancy, and after giving birth. Some participants will also take part in an interview to share their feedback on the program.
Frequently Asked Questions
What is Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes?
Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes is a clinical trial registered under NCT07372872. Current status: RECRUITING.
What is the status of NCT07372872?
The current status of NCT07372872 (Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes) is: RECRUITING.
When did Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes start?
Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.